Détail du document
Identifiant

oai:arXiv.org:2408.02225

Sujet
Mathematics - Combinatorics Computer Science - Discrete Mathem... 05C57, 05C75
Auteur
Clow, Alexander Huggan, Melissa A. Messinger, M. E.
Catégorie

Computer Science

Année

2024

Date de référencement

07/08/2024

Mots clés
attacking graphs cops $\attcop $g$ robbers
Métrique

Résumé

This paper considers the Cops and Attacking Robbers game, a variant of Cops and Robbers, where the robber is empowered to attack a cop in the same way a cop can capture the robber.

In a graph $G$, the number of cops required to capture a robber in the Cops and Attacking Robbers game is denoted by $\attCop(G)$.

We characterise the triangle-free graphs $G$ with $\attCop(G) \leq 2$ via a natural generalisation of the cop-win characterisation by Nowakowski and Winkler \cite{nowakowski1983vertex}.

We also prove that all bipartite planar graphs $G$ have $\attCop(G) \leq 4$ and show this is tight by constructing a bipartite planar graph $G$ with $\attCop(G) = 4$.

Finally we construct $17$ non-isomorphic graphs $H$ of order $58$ with $\attCop(H) = 6$ and $\cop(H)=3$.

This provides the first example of a graph $H$ with $\attCop(H) - \cop(H) \geq 3$ extending work by Bonato, Finbow, Gordinowicz, Haidar, Kinnersley, Mitsche, Pra\l{}at, and Stacho \cite{bonato2014robber}.

We conclude with a list of conjectures and open problems.

;Comment: 25 pages, 5 figures

Clow, Alexander,Huggan, Melissa A.,Messinger, M. E., 2024, Cops and Attacking Robbers with Cycle Constraints

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced